| FDA may limit anemia drug use for kidney disease - The Associated Press |
|
|
The Associated PressPre-dialysis kidney patients contributed 30 percent of Aranesp's revenue last year, estimates Robyn Karnauskas, an analyst at Deutsche Bank. ... read more |